Thiruvananthapuram: India is expected to see a sharp rise in Parkinson’s disease cases, potentially becoming the country with the second-highest number of patients globally, experts said at an international symposium in Kerala.

The warning was issued at the 6th International Annual Symposium 2026, organised by the King’s Parkinson’s Research Alliance India (PRAI). The event brought together global researchers, clinicians and policymakers to discuss emerging challenges and innovations in Parkinson’s care.

Younger patients on the rise

Experts said Parkinson’s, traditionally linked to older adults, is increasingly affecting younger people in Southeast Asia, including India. About 40–45% of Indian patients develop the disease between the ages of 22 and 49, with an average onset around 51 years.

India’s current prevalence is estimated at 15–43 per 100,000 people, with cases projected to rise sharply by 2030.

Kerala’s role highlighted

King’s College Hospital London CEO Kimberley Pierce said Kerala is taking a proactive role in addressing neurological disorders. She noted that India is likely to become the second-most affected country within the next five years.

She stressed the need for India-based research, focused on the country’s unique genetic and demographic profile, especially young-onset Parkinson’s.

Affordable treatment and innovation

Movement disorders specialist Dr Vinod Mehta said new technologies, including wearable treatment patches, are under development in collaboration with PRAI and King’s College Hospital, London.

He said such treatments currently cost about Rs 1 lakh per month, but local manufacturing in India could reduce this to Rs 1,000 per month, making them accessible to millions.

Key risk factors

Experts linked the rising burden to industrialisation, air pollution and lifestyle changes. In North India, a higher risk is associated with male gender, genetic history and head injuries.

Parkinson’s is the second most common neurodegenerative disorder in adults over 60. Experts called for stronger public health policies, early diagnosis, affordable medication, and improved access to advanced treatments such as dopamine therapy and Deep Brain Stimulation (DBS).

Focus on future strategy

The symposium also stressed the need to train healthcare professionals, strengthen research infrastructure, and improve public awareness to manage the growing Parkinson’s crisis in India.

ANI